Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dextrose-induced osmotic ultrafiltration is a core mechanism of peritoneal dialysis, where **high concentrations of dextrose in dialysate establish an osmotic gradient across the peritoneal membrane**. This gradient drives water from the blood vessels into the peritoneal cavity, removing excess fluid and solutes. The process relies on water transport through inter-endothelial pores and aquaporin-1 water channels, with effectiveness based on peritoneal membrane characteristics and dextrose concentration. While vital for fluid management in renal failure, long-term exposure to high glucose concentrations can lead to peritoneal membrane fibrosis, reduced efficacy (ultrafiltration failure), and metabolic complications such as hyperglycemia. Alternative non-glucose osmotic agents like icodextrin may be used to mitigate some risks.
Dextrose in dialysate establishes an **osmotic gradient** causing water from blood vessels to move into the peritoneal cavity Water is transported via inter-endothelial pores and aquaporin-1 channels
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic gradient via dextrose-induced ultrafiltration across the peritoneum.